Literature DB >> 3940695

Lipids, lipoproteins, and apoproteins in serum during infection.

C Alvarez, A Ramos.   

Abstract

We studied the alterations in the concentrations of total cholesterol, high-density lipoprotein cholesterol, triglycerides, and apoproteins A and B in serum of 54 patients hospitalized for various reasons, who developed sepsis during their stay. Forty of these patients required intensive care, 14 did not. Another group of patients with the same underlying pathological conditions was used as a control. We found the following: Sepsis causes the concentrations of total cholesterol, high-density lipoprotein cholesterol, and apoproteins A and B in serum to decrease, whereas triglycerides increase. However, these changes are not related to the infectious agent, the underlying illness, or the clinical situation of the patients. The return of serum lipids to more normal concentrations parallels the recovery from sepsis. The positive correlation between the drastically decreased concentrations of high-density lipoprotein cholesterol and the severe hypoalbuminemia in these patients suggests a common pathway for these two abnormalities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940695

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  55 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levels.

Authors:  K M Wasan; F W Strobel; S C Parrott; M Lynn; W J Christ; L D Hawkins; D P Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  Adrenal-exhaustion syndrome in patients with liver disease.

Authors:  Paul E Marik
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

4.  Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.

Authors:  P Alvarez; F Genre; M Iglesias; J J Augustin; E Tamayo; J C Escolà-Gil; B Lavín; F Blanco-Vaca; R Merino; J Merino
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

5.  Low serum total cholesterol concentrations and mortality in middle aged British men.

Authors:  G Wannamethee; A G Shaper; P H Whincup; M Walker
Journal:  BMJ       Date:  1995-08-12

6.  Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet.

Authors:  Beatrice Morio; Oivind Irtun; David N Herndon; Robert R Wolfe
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

7.  Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment.

Authors:  Ric M Procyshyn; Kishor M Wasan; Allen E Thornton; Alasdair M Barr; Eric Y H Chen; Edith Pomarol-Clotet; Emmanuel Stip; Richard Williams; G William Macewan; C Laird Birmingham; William G Honer
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

8.  Endotoxin levels correlate positively with a sedentary lifestyle and negatively with highly trained subjects.

Authors:  Fabio S Lira; Jose C Rosa; Gustavo D Pimentel; Hélio A Souza; Erico C Caperuto; Luiz C Carnevali; Marília Seelaender; Ana R Damaso; Lila M Oyama; Marco T de Mello; Ronaldo V Santos
Journal:  Lipids Health Dis       Date:  2010-08-04       Impact factor: 3.876

9.  The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution.

Authors:  Li Tian; Yanhua Xu; Mingde Fu; Tao Peng; Yinghui Liu; Shiyin Long
Journal:  Lipids Health Dis       Date:  2011-01-21       Impact factor: 3.876

10.  Plasma levels of apolipoprotein A1 in malaria-exposed primigravidae are associated with severe anemia.

Authors:  David C Simpson; Edward Kabyemela; Atis Muehlenbachs; Yuko Ogata; Theonest K Mutabingwa; Patrick E Duffy; Michal Fried
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.